Cargando…
Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study
OBJECTIVES: We examined loop diuretic treatment before and 1-year after transcatheter aortic valve implantation (TAVI), as a proxy for changes in symptom severity and secondly assessed how changes in loop diuretics related to mortality risk. BACKGROUND: Randomized clinical trials suggest that approx...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019742/ https://www.ncbi.nlm.nih.gov/pubmed/36928217 http://dx.doi.org/10.1371/journal.pone.0282636 |
_version_ | 1784908092439265280 |
---|---|
author | Begun, Xenia Butt, Jawad Haider Kristensen, Søren Lund Weeke, Peter Ejvin De Backer, Ole Schou, Morten Køber, Lars Loldrup Fosbøl, Emil |
author_facet | Begun, Xenia Butt, Jawad Haider Kristensen, Søren Lund Weeke, Peter Ejvin De Backer, Ole Schou, Morten Køber, Lars Loldrup Fosbøl, Emil |
author_sort | Begun, Xenia |
collection | PubMed |
description | OBJECTIVES: We examined loop diuretic treatment before and 1-year after transcatheter aortic valve implantation (TAVI), as a proxy for changes in symptom severity and secondly assessed how changes in loop diuretics related to mortality risk. BACKGROUND: Randomized clinical trials suggest that approximately one third of patients undergoing TAVI do not achieve symptom relief, but “all-comer” data are lacking. METHODS: Using Danish nationwide registries, we identified all citizens, who underwent TAVI from 2008 to 2019 and were alive at 1-year post-discharge. Loop diuretic treatment pre-TAVI and at 1-year post-TAVI were assessed and grouped as receiving 1) no-loop diuretics; 2) low: 1–40 mg of furosemide (or equivalent bumetanide) daily; 3) intermediate: 41–120 mg of furosemide daily; or 4) high: >120 mg furosemide daily. RESULTS: Among the 4431 patients undergoing TAVI, 2173 (49%) patients were not treated with loop diuretics at the time of TAVI, 918 (21%) had low-loop diuretics, 881 (20%) had intermediate-loop diuretics, and 459 (10%) had high-loop diuretics. At 1-year post-TAVI, 893 (20%) patients had increased, 1010 (23%) had reduced, and 2528 (57%) had unchanged loop diuretic treatment. The cumulative 5-year risk of death in patients surviving one year, was 61% (95% CI: 56.4% to 65.3%) in patients with increased and 47% (95% CI: 44.9% to 49.9%) in patients with reduced/unchanged loop diuretic treatment, respectively. In multivariable Cox proportional hazard analysis, increased loop diuretic treatment was associated with a higher risk of death compared with reduced/unchanged loop diuretic treatment (Hazard ratio: 1.4; 95% CI: 1.22 to 1.52). CONCLUSIONS: Among patients undergoing TAVI, surviving one year, one fifth of patients had increased loop diuretic treatment, and a little over one fifth had reduced loop diuretic treatment 1-year post-procedure. In patients with increased diuretic treatment, the risk of death was higher compared to those with reduced/unchanged loop diuretic treatment. |
format | Online Article Text |
id | pubmed-10019742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-100197422023-03-17 Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study Begun, Xenia Butt, Jawad Haider Kristensen, Søren Lund Weeke, Peter Ejvin De Backer, Ole Schou, Morten Køber, Lars Loldrup Fosbøl, Emil PLoS One Research Article OBJECTIVES: We examined loop diuretic treatment before and 1-year after transcatheter aortic valve implantation (TAVI), as a proxy for changes in symptom severity and secondly assessed how changes in loop diuretics related to mortality risk. BACKGROUND: Randomized clinical trials suggest that approximately one third of patients undergoing TAVI do not achieve symptom relief, but “all-comer” data are lacking. METHODS: Using Danish nationwide registries, we identified all citizens, who underwent TAVI from 2008 to 2019 and were alive at 1-year post-discharge. Loop diuretic treatment pre-TAVI and at 1-year post-TAVI were assessed and grouped as receiving 1) no-loop diuretics; 2) low: 1–40 mg of furosemide (or equivalent bumetanide) daily; 3) intermediate: 41–120 mg of furosemide daily; or 4) high: >120 mg furosemide daily. RESULTS: Among the 4431 patients undergoing TAVI, 2173 (49%) patients were not treated with loop diuretics at the time of TAVI, 918 (21%) had low-loop diuretics, 881 (20%) had intermediate-loop diuretics, and 459 (10%) had high-loop diuretics. At 1-year post-TAVI, 893 (20%) patients had increased, 1010 (23%) had reduced, and 2528 (57%) had unchanged loop diuretic treatment. The cumulative 5-year risk of death in patients surviving one year, was 61% (95% CI: 56.4% to 65.3%) in patients with increased and 47% (95% CI: 44.9% to 49.9%) in patients with reduced/unchanged loop diuretic treatment, respectively. In multivariable Cox proportional hazard analysis, increased loop diuretic treatment was associated with a higher risk of death compared with reduced/unchanged loop diuretic treatment (Hazard ratio: 1.4; 95% CI: 1.22 to 1.52). CONCLUSIONS: Among patients undergoing TAVI, surviving one year, one fifth of patients had increased loop diuretic treatment, and a little over one fifth had reduced loop diuretic treatment 1-year post-procedure. In patients with increased diuretic treatment, the risk of death was higher compared to those with reduced/unchanged loop diuretic treatment. Public Library of Science 2023-03-16 /pmc/articles/PMC10019742/ /pubmed/36928217 http://dx.doi.org/10.1371/journal.pone.0282636 Text en © 2023 Begun et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Begun, Xenia Butt, Jawad Haider Kristensen, Søren Lund Weeke, Peter Ejvin De Backer, Ole Schou, Morten Køber, Lars Loldrup Fosbøl, Emil Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study |
title | Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study |
title_full | Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study |
title_fullStr | Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study |
title_full_unstemmed | Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study |
title_short | Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study |
title_sort | diuretic treatment before and after transcatheter aortic valve implantation: a danish nationwide study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019742/ https://www.ncbi.nlm.nih.gov/pubmed/36928217 http://dx.doi.org/10.1371/journal.pone.0282636 |
work_keys_str_mv | AT begunxenia diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy AT buttjawadhaider diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy AT kristensensørenlund diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy AT weekepeterejvin diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy AT debackerole diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy AT schoumorten diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy AT køberlars diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy AT loldrupfosbølemil diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy |